Artificial intelligence

The Deep 6 AI team enjoyed a busy few days at MAGI West in Las Vegas last week. Over 700 industry professionals attended more than 100 sessions and workshops to learn from each other about how they can improve their clinical research operations. We joined...

Deep 6 AI's success with Cedars-Sinai was recently discussed in an article from Nature on "An AI boost for clinical trials".   The article outlines the outdated and challenging methods researchers use to find and recruit patients for crucial clinical trials. Then the article details how software...

We’re thrilled to share that Forbes chose to include Deep 6 AI on its AI 50 list of America’s Most Promising Artificial Intelligence Companies. The list focused on “U.S.-based companies that are wielding some subset of artificial intelligence in a meaningful way and demonstrating real...

Cohort Builder v3.1  Deep 6 AI's Cohort Builder is a software tool researchers can use to find more, better-matching patients for clinical trials. It allows research staff to search structured and unstructured data in the Electronic Medical Record (EMR), looking at millions of documents in a...

May is Cancer Research Month so we asked our Chief Oncologist, Dr. BJ Rimel, and our lead data scientist, Scott Hoch, to shed some light on how Deep 6 is helping advance cancer research through AI-enabled Clinical Trial Acceleration Software.   Deep 6 AI: Why is oncology...

Did you know that the first clinical trial ever conducted began aboard a 50-gun ship patrolling the English Channel on May 20, 1747?  James Lind was the P.I. investigating innovative new preventative treatments for scurvy. Finding patients for his trial was easy as there were...

Deep 6 AI's Cohort Builder is a software tool researchers can use to assist with identifying patients for clinical trials. It allows research staff to search structured and unstructured data in the EMR; looking at millions of documents in a matter of seconds. Once you’ve...

AI Pharma In Innovation called out Deep 6 as a company that is tackling one of the hardest problems in medical research.   Did you know that 90% of drugs that reach clinical stage development never make it to FDA approval and commercialization? And that of the...

Created specifically for multi-site research collaboration, CROs, and study sponsors, our Patient Panorama offers a real-time view of aggregate patient population data across numerous sites.   This allows researchers to work together across health systems and helps sponsors with their trial design and site selection, based on real-time aggregated data and effortless site feedback. Starting your next clinical...